Canopy Growth Q2 revenue $67M (+6% YoY); going concern doubt resolved

Canopy Growth Corp

2026-Q2 EPS reported -$0.19 revenue$138,817,000

Canada adult-use net revenue $24M, up 30% YoY; Canada medical $22M, up 17%.
Consolidated gross margin 33% (down 200bps YoY, up 800bps sequentially).
Operating loss improved 63% to $17M; Adjusted EBITDA loss narrowed to $3M from $6M.
Cash $298M exceeds debt by $70M; going concern doubt resolved. Prepaid US$50M on term loan.
SG&A down 13% YoY; $21M annualized savings captured since March 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.